Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Equity Ratio (2019 - 2025)

Eton Pharmaceuticals' Equity Ratio history spans 7 years, with the latest figure at 0.22 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 50.37% year-over-year to 0.22; the TTM value through Sep 2025 reached 0.22, down 50.37%, while the annual FY2024 figure was 0.32, 34.19% down from the prior year.
  • Equity Ratio for Q3 2025 was 0.22 at Eton Pharmaceuticals, down from 0.24 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.69 in Q2 2021 and bottomed at 0.22 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.52 (2022), against an average of 0.49.
  • The largest annual shift saw Equity Ratio surged 383.21% in 2021 before it crashed 50.37% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.64 in 2021, then decreased by 18.6% to 0.52 in 2022, then fell by 6.67% to 0.49 in 2023, then plummeted by 34.19% to 0.32 in 2024, then crashed by 31.04% to 0.22 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Equity Ratio are 0.22 (Q3 2025), 0.24 (Q2 2025), and 0.29 (Q1 2025).